Before this development, there were no public indications of any health issues regarding Ajay Rai. His activities had been consistent with his role in the Congress party.

However, the situation changed when Modi publicly acknowledged Rai’s health concerns. This moment marks a significant shift in the political landscape, as leaders often address health issues of opponents or allies.

The immediate effect is a demonstration of goodwill from Modi towards Rai. Such gestures can influence public perception and political dynamics in Uttar Pradesh.

Modi stated, “मैं श्री अजय राय के शीघ्र स्वस्थ होने की कामना करता हूँ।” This message reflects a level of respect that transcends political rivalry.

Political analysts suggest that such expressions can foster a more collaborative atmosphere among parties. It highlights the importance of health and well-being in political discourse.

Yet, it remains unclear what specific health issues Rai is facing. No details have been shared publicly about his condition.

This incident underscores how social media platforms serve as vital communication tools for politicians. Leaders can quickly convey their messages and sentiments to a broad audience.

The post Narendra Modi expresses concern for Ajay Rai’s health appeared first on newscri.

The employee, feeling unwell, sought a doctor’s advice and obtained a certificate recommending two days of rest. Following this, he applied for sick leave through the HR portal, which was subsequently approved. However, the manager refused to accept the HR-approved sick leave, insisting on seeing the prescription, thus challenging the authority of the HR department and the employee’s health needs.

This incident has sparked a strong reaction on social media platforms like Reddit, where users have described the manager’s behavior as indicative of toxic workplace norms. One user remarked, “Choose health over donkeys. If sick leave is policy-backed and HR-approved, your manager has no business gatekeeping it.” This sentiment resonates with many who believe that employee health should take precedence over rigid managerial policies.

The situation highlights a broader issue within workplace cultures, particularly in India, where the stigma surrounding sick leave can discourage employees from taking necessary time off for health reasons. The reluctance to accept single-day sick leaves can lead to a culture of presenteeism, where employees feel pressured to work despite being unwell, potentially exacerbating health issues and affecting overall productivity.

Moreover, the conversation around sick leave is not limited to individual cases. On a global scale, more than 2.4 billion workers are exposed to excessive heat, contributing to over 22.85 million occupational injuries each year. In India, projections indicate that the country could lose about 5.8% of working hours by 2030 due to heat stress, a significant increase from 4.3% in 1995. The extreme heat in 2023 alone cost India an estimated 181 billion potential labour hours, translating into income losses of about Rs 13 lakh crore (approximately $141 billion).

In Spain, the issue of sick leave verification and monitoring has also become a topic of public debate, with statistics showing that the country recorded 53.7 temporary disability cases per 1,000 workers in 2025. This has led to increased scrutiny regarding how sick leave is granted and managed, emphasizing the need for policies that prioritize employee health while ensuring accountability.

As discussions continue, observers note that longer wait times for diagnostics, rehabilitation, or specialist visits can extend leave durations, further complicating the sick leave landscape. The need for a balanced approach that respects both employee health and workplace productivity is becoming increasingly evident.

In light of these developments, it remains to be seen how companies will adapt their sick leave policies to better accommodate employee health needs while addressing managerial concerns. The ongoing dialogue around sick leave practices is crucial for fostering healthier work environments and ensuring that employees feel supported in taking the time they need to recover.

The post Sick Leave Policies Under Scrutiny Amid Controversial Denial appeared first on newscri.

Mojtaba Khamenei, recently chosen as the successor to his father, Ali Khamenei, is currently in critical condition in Qom, Iran. His health has deteriorated significantly following a US-Israel joint airstrike that occurred earlier this month.

Reports indicate that Mojtaba Khamenei is unable to fulfill his leadership duties due to his severe injuries. He has been in a coma since the airstrike, which resulted in significant facial injuries and the amputation of a leg.

Tragically, Ali Khamenei and several family members were confirmed killed in the same airstrike, marking a pivotal moment in Iran’s leadership. Preparations for Ali Khamenei’s burial site are reportedly underway in Qom, further underscoring the gravity of the situation.

Mojtaba Khamenei, aged 56, has not been seen in public since his appointment as the successor in early March 2026. His absence raises questions about the future leadership of Iran and the potential implications for the country.

Details remain unconfirmed regarding the exact status of Mojtaba Khamenei’s health, leaving observers uncertain about the leadership transition in Iran. The situation is evolving, and many are closely monitoring developments as they unfold.

The airstrike that incapacitated Mojtaba Khamenei has not only impacted his health but also the political landscape in Iran. With the distance from Tehran to Qom being approximately 140 kilometers, the implications of this crisis are felt throughout the nation.

As the nation grapples with the loss of its Supreme Leader and the potential successor’s critical condition, the future of Iran’s governance remains uncertain. Observers are left to speculate on the next steps for the Iranian leadership amidst this turmoil.

The post ഇറാന്റെ പരമോന്നത നേതാവ്: Iran’s Supreme Leader appeared first on newscri.

“Together for health. Stand with science,” is the rallying cry for World Health Day 2026, which will be observed on April 7. This year’s theme emphasizes the vital role of scientific collaboration in safeguarding public health.

The campaign aims to celebrate the power of scientific collaboration to protect health, focusing on the One Health approach, which recognizes the interconnectedness of human, animal, and environmental health. This approach is increasingly relevant as global health challenges continue to evolve.

On the same day, the International One Health Summit will take place, bringing together experts and stakeholders to discuss pressing health issues. Additionally, the inaugural Global Forum of WHO Collaborating Centres will be held from April 7 to 9, 2026.

Nearly 800 scientific institutions from over 80 countries are expected to gather for this significant event, highlighting the global commitment to health and science. This unprecedented gathering will facilitate discussions on collaborative strategies to address health challenges worldwide.

In a call to action, organizers state, “We call on governments, scientists, health workers, partners, and the public to stand with science to protect lives, rebuild trust, and secure a healthier future.” This statement underscores the importance of unity in the face of health crises.

The campaign invites participation through the hashtags #StandWithScience and #WorldHealthDay, encouraging individuals and organizations to share their commitment to health and science on social media platforms.

World Health Day has been celebrated annually on April 7, serving as a reminder of the importance of health awareness and action. The events planned for 2026 aim to foster a collaborative environment where innovative solutions can be developed.

As the date approaches, further details regarding the summit and forum will be provided, ensuring that participants are well-informed and prepared for the discussions ahead. Details remain unconfirmed.

The post World Health Day 2026: Together for health. Stand with science. appeared first on newscri.

On 2 April 2026, World Autism Awareness Day will be observed, bringing attention to the fact that 1 in 127 people is diagnosed with autism. This lifelong neurodevelopmental condition significantly affects social interaction, communication, and behavior.

Autism is recognized as one of the top 10 brain health conditions contributing to health loss globally. Despite this, access to timely and quality health care and support services for autistic individuals remains limited, highlighting a critical gap in public health initiatives.

According to the World Health Organization (WHO), early identification, inclusive education, and nurturing care can greatly enhance the health, well-being, and participation of autistic individuals in society. WHO continues to promote inclusive environments and provides essential support for autistic people and their caregivers.

In conjunction with World Autism Awareness Day, the Purnima festival will also be observed on 1 and 2 April 2026. Purnima is regarded as a fortunate day for worshipping the Moon God and reciting the Satyanarayan Katha, with devotees fasting from sunrise to sunset.

The Purnima Tithi begins on April 1, 2026, at 07:06 AM and ends on April 2, 2026, at 07:41 AM. This overlap of events underscores the importance of community and support, both for spiritual and health-related causes.

Despite international human rights conventions, autistic individuals still face stigma, discrimination, and barriers to participation in society. This day serves as a reminder of the ongoing challenges and the need for greater awareness and advocacy.

Looking ahead, a webinar is scheduled for April 27 to mark the launch of a new WHO caregiver well-being training program aimed at supporting children with developmental delays and neurodevelopmental conditions. This initiative is expected to provide valuable resources for caregivers and enhance the quality of care for affected children.

As the observance of World Autism Awareness Day approaches, observers are encouraged to participate in discussions and activities that promote understanding and support for the autistic community. Details remain unconfirmed regarding specific events and initiatives planned for the day.

The post 2 april 2026: World Autism Awareness Day on appeared first on newscri.

The BA.3.2 variant, commonly referred to as the Cicada variant, is a descendant of the BA.3 subvariant of Omicron that emerged in 2022. It was first identified in South Africa in November 2024 and has since been detected in over 20 countries, including 25 states in the United States. With approximately 70 to 75 mutations in its spike protein, the Cicada variant has raised concerns among health officials and the public alike.

Initial reports indicate that common symptoms associated with the Cicada variant include cough, fever or chills, sore throat, congestion, shortness of breath, loss of smell or taste, fatigue, headache, and gastrointestinal issues such as diarrhea or vomiting. These symptoms largely mirror those of previous COVID-19 strains, particularly the Omicron variants.

Despite the presence of these symptoms, current evidence suggests that the BA.3.2 variant does not cause more severe illness compared to earlier variants. Dr. Adolfo García-Sastre stated, “There’s no evidence that BA.3.2 is causing more severe disease or hospitalizations in countries where it’s more widespread.” Most cases appear to be mild to moderate, resembling flu-like illness, especially among vaccinated individuals.

Health experts emphasize that the current COVID-19 vaccines are expected to provide strong protection against severe disease, even if breakthrough infections occur. However, there are concerns regarding the variant’s multiple mutations, which may impact vaccine effectiveness. Observers note that while the vaccines may not be as effective against the Cicada variant, they still offer significant protection against severe outcomes.

The Cicada variant primarily spreads through respiratory droplets and close contact in crowded or poorly ventilated spaces, similar to other COVID-19 variants. Health authorities are actively monitoring its rise, particularly in the United States, where cases are currently increasing.

Health experts recommend that individuals stay up to date with vaccinations and take precautions in crowded settings to mitigate the spread of the virus. As the situation develops, health officials continue to assess the variant’s impact and provide guidance to the public.

In summary, the symptoms linked to the Cicada variant remain largely consistent with previous COVID-19 strains, and there is no strong evidence suggesting increased severity of illness caused by this variant. Most cases remain mild and can be managed at home with rest and hydration. Details remain unconfirmed as health authorities continue to gather data on this emerging variant.

The post Cicada COVID Variant Symptoms appeared first on newscri.

The Cicada COVID-19 variant, classified as BA.3.2 and part of the Omicron family, has emerged as a significant concern in India. This variant was first identified in South Africa in November 2024 and has since been detected in over 22 countries.

As of now, the Cicada variant carries approximately 75 mutations, with more than 50 of these located in the spike protein. This extensive mutation profile raises questions about its potential to evade immunity from previous infections or vaccinations.

Symptoms associated with the Cicada variant include cough, extreme fatigue, runny nose, headache, sore throat, mild fever, muscle and joint pain, loss of taste or smell, night sweats, and rash. However, it is important to note that the Cicada variant has not been confirmed to cause more severe illness compared to earlier variants.

The first confirmed case of the Cicada variant in the United States was reported in June 2025, and by January 2026, three patients had been confirmed, all of whom recovered. This variant’s spread is being closely monitored by health authorities.

Dr. Robert Hopkins Jr. stated, “It is possible we will see Cicada become the dominant strain in the U.S., but that is by no means certain.” This highlights the uncertainty surrounding the variant’s impact and prevalence.

The Centers for Disease Control and Prevention (CDC) emphasized the importance of monitoring the spread of BA.3.2, noting that it provides valuable information about the potential for this new SARS-CoV-2 lineage to evade immunity.

As the situation develops, health officials in India and around the world are on high alert. The emergence of the Cicada variant underscores the ongoing challenges posed by COVID-19 and its evolving strains.

Details remain unconfirmed regarding the full extent of the variant’s impact and its implications for public health. Continued vigilance and research are essential as the global community navigates this new phase of the pandemic.

The post Cicada COVID Variant in India: Latest Developments appeared first on newscri.

The recent outbreaks of the Nipah virus in Kerala, India, raise the critical question: how is the region responding to this persistent health threat? Kerala has experienced multiple Nipah virus outbreaks, with significant incidents occurring in 2018 and 2023, leading to increased vigilance among health-care workers and authorities.

The Nipah virus, first identified in Malaysia in 1999, is transmitted to humans through infected animals or contaminated food. As of 2026, Kerala has reported two deaths attributed to the virus, with a total of 18 confirmed cases during the initial outbreak in 2018, which also saw 17 fatalities.

In recent developments, two laboratory-confirmed cases were recorded in West Bengal on January 26, 2026, involving health-care workers who slipped into a coma. This incident has heightened awareness and concern regarding the virus’s potential spread beyond Kerala.

Health officials have identified approximately 700 individuals on the contact list for Nipah virus risk, with 77 categorized as high-risk. The Nipah virus infection can lead to severe symptoms, including fever, headache, muscle pain, and respiratory issues, making early detection and response crucial.

Notably, the fruiting season in Kerala, which peaks around April, correlates with an increase in Nipah virus cases. Deforestation and urban expansion have been cited as factors that amplify the risk of transmission, prompting calls for better surveillance and preparedness.

Dr. Anish, a local health expert, emphasized the importance of preventive measures, stating, “Avoiding fruits lying on the ground or those bitten by bats, washing and peeling fruits before consumption, and keeping away from bat roosts are some of the steps suggested to avoid the infection.”

Despite these measures, scientists have criticized the current state of surveillance and preparedness as poor and episodic, with funding for research being sporadic. They warn that the danger of the Nipah virus lies in its periodic and lethal nature, underscoring the need for consistent public health strategies.

Awareness campaigns targeting children are planned in Kerala due to the history of infections in that age group. As health officials work to mitigate the risks associated with the Nipah virus, the community remains vigilant, with ongoing efforts to educate the public about prevention and response strategies.

Details remain unconfirmed regarding the full extent of the current outbreaks, but health authorities continue to monitor the situation closely.

The post Nipah virus: Update on Outbreaks in Kerala, India appeared first on newscri.

In a significant public health update, it has been reported that tuberculosis (TB) claimed the lives of 1.23 million individuals worldwide in 2024. This alarming statistic underscores TB’s status as the leading cause of death from a single infectious agent.

According to estimates, 10.7 million people fell ill with TB globally during the same year. The disease, primarily affecting the lungs, remains a critical health challenge, particularly in regions with high rates of HIV infection.

Notably, individuals living with HIV are 12 times more likely to develop TB compared to those without the virus. In 2024, approximately 150,000 people died from HIV-associated TB, highlighting the intersection of these two public health crises.

Despite being preventable and curable, access to treatment remains a significant issue. Only about 61% of the estimated number of people living with HIV who developed TB received antiretroviral therapy (ART) in 2024. Furthermore, only 2 in 5 individuals with drug-resistant TB accessed necessary treatment.

The World Health Organization (WHO) has identified multidrug-resistant TB (MDR-TB) as a public health crisis and a health security threat. The largest number of new TB cases in 2024 was reported in the WHO South-East Asia Region, accounting for 34% of cases.

To combat this growing crisis, an estimated US$ 22 billion is needed annually for TB prevention, diagnosis, treatment, and care to meet global targets by 2027. This financial requirement emphasizes the urgent need for increased investment in TB control measures.

In a related context, India has expanded its energy import sources from 27 countries to 41 over the past 11 years, reflecting a broader strategy to enhance its energy security.

Prime Minister Modi stated, “India has always stood for peace in the interest of humanity and dialogue and diplomacy are the only solutions to this problem.” He also assured that the government is ensuring smooth supplies of petrol, diesel, oil, gas, and fertilizers.

As global health officials continue to address the TB epidemic, the need for comprehensive strategies and international cooperation remains critical. Details remain unconfirmed regarding further measures being implemented to tackle this pressing health issue.

The post Today News: Tuberculosis Deaths Reach 1.23 Million in 2024 appeared first on newscri.

On March 23, 2026, the daily horoscope for Cancer emphasizes the importance of calmness and focus. As the day unfolds, individuals under this sign are encouraged to make small choices that can lead to steady progress in various aspects of their lives.

Support from friends is highlighted as a key factor that can help ease any pressure that may arise throughout the day. This supportive network is crucial for maintaining emotional stability and fostering a positive atmosphere.

In the workplace, Cancers are advised to avoid gossip and to keep a close eye on deadlines. Staying focused on tasks will be essential to ensure productivity and maintain a good reputation among colleagues.

Financial matters also take center stage today, with a strong recommendation to favor careful choices. The alignment of Jupiter and the Moon suggests potential financial relief, making it a favorable day for making prudent investments.

Romantically, nurturing connections are expected to bloom, offering opportunities for deeper bonds. Cancers may find themselves more open to expressing their feelings, which can enhance their relationships.

Health remains stable, with a gentle emotional uplift noted in the horoscope. A small positive change can raise stamina and improve mood, contributing to overall well-being.

Cancers are encouraged to invest energy towards fixed deposits or mutual funds, as today presents a good opportunity for financial planning. Keeping a cautious approach to spending is advised, with reminders to “keep your wallet closed for fancy shopping.”

Today’s lucky number for Cancer is 2, and the lucky color is white, which may bring additional positive energy throughout the day.

As the day progresses, it is clear that the guidance provided in the horoscope can significantly impact the decisions made by those under the Cancer sign. The emphasis on calmness, focus, and supportive relationships highlights the importance of a balanced approach to daily challenges.

Overall, the insights from today’s cancer horoscope serve as a reminder of the potential for growth and stability when navigating both personal and professional spheres.

The post Cancer Horoscope Today Astrology appeared first on newscri.